Related Experiment Video

Updated: Aug 8, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Is HCV infection associated with liver steatosis also in children?

Antonietta Giannattasio1, Maria Immacolata Spagnuolo, Angela Sepe

  • 1Department of Pediatrics, University Federico II, Naples, Italy.

Journal of Hepatology
|June 6, 2006
PubMed

Insights

Steatosis (fatty liver) affects a quarter of children with chronic hepatitis C (CHC). Children with steatosis show more severe fibrosis and a lower sustained response to interferon therapy.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Viral Hepatitis Research

Background:

  • The prevalence and clinical significance of steatosis in pediatric chronic hepatitis C (CHC) are not well-established.
  • Understanding steatosis in children with CHC is crucial for disease management and treatment outcomes.

Purpose of the Study:

  • To analyze the prevalence of steatosis in children diagnosed with CHC.
  • To investigate the relationship between steatosis and clinical features, laboratory findings, and interferon treatment response in pediatric CHC patients.

Main Methods:

  • Retrospective evaluation of 64 pediatric patients with CHC who underwent liver biopsy.
  • Assessment of steatosis, necroinflammation, fibrosis, and body mass index (BMI).
  • Analysis of interferon treatment response in patients with and without steatosis.

Main Results:

  • Twenty-five percent of children with CHC exhibited mild to moderate steatosis.
  • Steatosis was not significantly associated with BMI, but patients with steatosis showed a trend towards higher fibrosis scores (P<0.05).
  • Children with steatosis had significantly lower rates of sustained response to interferon therapy (23%) compared to those without steatosis (53%).

Conclusions:

  • Histological steatosis is present in approximately 25% of children with CHC, potentially independent of metabolic factors.
  • Pediatric CHC patients with steatosis may experience more advanced fibrosis.
  • Steatosis in pediatric CHC is associated with a poorer sustained virologic response to interferon therapy.
Abstract

More Related Videos

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...